The infection causes the body’s cells to change their processes. Almost all cells begin to produce substances that help to defeat the disease and recover quickly. Interferon (IFN) is one of these substances.

The same IFN molecule can trigger different processes in cells: antiviral, antitumor, or regulating the work of the immune system. Which process is initiated depends on the concentration of IFN molecules and the type of cell it affects.

All cells, except for nerve cells and red blood cells, can trigger antiviral processes when interferon-stimulated. However, the antitumor and immunomodulatory mechanisms of IFN can only be activated in certain types of cells.

Another vital feature of interferons is interferon preparations’ ability to stimulate the body’s production of interferon.

These features of interferons are used to treat and prevent a wide range of diseases.

Сontents

Acute respiratory viral infections (ARVI)

Acute respiratory diseases are caused by viruses that can infect the body’s epithelial cells: cells of the respiratory tract, digestive tract, and mucous membranes. ARVI – the most common disease. Interferons have been used to prevent respiratory diseases for 60 years.

Treatment of ARVI with interferons became intensively studied during the COVID-19 pandemic. Large-scale clinical trials were conducted in 2020 in different countries: China, Great Britain, Iran, Russia, and Cuba.

COVID-19 and other coronavirus infections

Coronaviruses are the most unpredictable family of viruses that cause acute respiratory diseases. Infected animals infect humans with coronaviruses, and the virus begins to circulate in the human population. Some coronaviruses are low-risk and not very contagious. They are constantly present as seasonal colds.

Other coronaviruses are very dangerous but not very contagious. For example, the SARS-CoV or the virus that causes the Middle East Respiratory Syndrome (MERS-CoV).

At the end of 2019, a new coronavirus, SARS-CoV-2, appeared among people. It is very dangerous because it has many mechanisms for suppressing the interferon system. It is also the most contagious among coronaviruses. It is this virus that causes the coronavirus disease COVID-19, which was declared a pandemic in 2020.

The role of interferons in the evolution of vertebrates

Prevention of COVID-19 COVID-19

Treatment of COVID-19

Clinical studies of coronavirus infections 2020-2021, state, international and expert recommendations

The origin of future coronaviruses

Do cats get coronavirus, and which animals can spread SARS-CoV-2?

Inhaled interferon-beta is effective and safe in treating SARS-CoV-2

British randomized, double-blind, placebo-controlled trial, Phase 2

Interferon-alpha to protect people with immune suppression from COVID-19

No patients infected with COVID-19 within 45 days of the study


Influenza and other acute respiratory infections

Clinical studies of ARVI and influenza

Influenza vaccination has a positive effect on the survival of patients with cardiovascular diseases

Scientists believe that it is necessary to continue to vaccinate this population group

The experts: how to cope with SARS, flu, and coronavirus — tips and answers to readers’ questions

Do prevention, comply with safety requirements, if you get sick — consult a doctor.

SARS prevention raises allergy treatment effect

Interferon-alpha-2b and loratadine-based nasal medications contribute to the treatment regimen preservation of allergic diseases during the SARS epidemic



Eye diseases

Clinical studies of eye diseases

Interferons alpha-2a and alpha-2b for eye diseases

Interferons' treatment of the anterior and posterior segments of the eyeball

Dry eye disease in-time treatment

Eye hygiene, warm compresses and diet help restore homeostasis of the tear film



Hepatitis B and C

Clinical studies of hepatitis B and C, expert opinions

Is large-scale screening of the population for the hepatitis C virus justified?

Most Hep C virus hosts never show symptoms of the disease. For them, the side effects of treatment may exceed the clinical benefit

New treatment for hepatitis C: faster effect, better survival rate

While scientists argue what is more harmful: the disease itself or the side effects of drugs, the hepatitis C community in the United States shares good news. Modern hepatitis C therapy in 97% of cases passes without serious health consequences within 2 years